Skip to content

BOLD - Boundless Bio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchB

Boundless Bio, Inc. Common Stock

BOLD · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

B

BOLDBoundless Bio, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.01
52-wk low: $0.96
Prev close: $1.92
Mkt cap: $65.1M
Beta: 0.38
P/B: 1.0x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$9.5M

MI
Millennium
Israel Englander · Q2 2026 13F
$1.2M
position
JS
Jim Simons

Earnings

Reported Aug 4, 2026

Earnings came in 82.8% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $65M

Valuation

P/B0.99

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: BOLD
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $65.06M
Beta: 0.38

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-67.9%

Q2 2026 13F

$1.2M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$363K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for BOLD

No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.06-82.8%

-$0.58 expected

Next report

What the street expects next

-67.9%

ROA-32.8%

Growth

Beta0.38